Susan Deng

404 total citations
15 papers, 321 citations indexed

About

Susan Deng is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Susan Deng has authored 15 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Immunology and 3 papers in Genetics. Recurrent topics in Susan Deng's work include Histone Deacetylase Inhibitors Research (13 papers), Protein Degradation and Inhibitors (7 papers) and Immune cells in cancer (5 papers). Susan Deng is often cited by papers focused on Histone Deacetylase Inhibitors Research (13 papers), Protein Degradation and Inhibitors (7 papers) and Immune cells in cancer (5 papers). Susan Deng collaborates with scholars based in United States, China and Chile. Susan Deng's co-authors include John J. Powers, Eva Sahakian, Alejandro Villagra, Javier Pinilla‐Ibarz, Eduardo M. Sotomayor, Fengdong Cheng, Karrune Woan, Maritza Lienlaf, Patricio Perez-Villarroel and Allison Distler and has published in prestigious journals such as Blood, Cancer Research and Journal of Leukocyte Biology.

In The Last Decade

Susan Deng

14 papers receiving 319 citations

Peers

Susan Deng
Ben P. Martin Australia
Kellie-Marie Banks Australia
Laura Esteban-Burgos Spain
Fanjun Cheng China
Robert J. Van Gulick United States
Clemens Spinnler Sweden
Bonnie Huor Canada
Caterina Mezzatesta Italy
Hélène Ste-Croix Canada
Lars A.T. Meijer Netherlands
Ben P. Martin Australia
Susan Deng
Citations per year, relative to Susan Deng Susan Deng (= 1×) peers Ben P. Martin

Countries citing papers authored by Susan Deng

Since Specialization
Citations

This map shows the geographic impact of Susan Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Deng more than expected).

Fields of papers citing papers by Susan Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Deng. The network helps show where Susan Deng may publish in the future.

Co-authorship network of co-authors of Susan Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Deng. A scholar is included among the top collaborators of Susan Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Deng. Susan Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Powers, John J., Susan Deng, Steven N. Quayle, et al.. (2018). Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia. Blood Advances. 2(21). 3012–3024. 14 indexed citations
2.
Sahakian, Eva, Jie Chen, John J. Powers, et al.. (2017). Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology. Journal of Leukocyte Biology. 102(2). 475–486. 48 indexed citations
3.
Powers, John J., Maritza Lienlaf, Patricio Perez-Villarroel, et al.. (2016). Expression and Function of Histone Deacetylase 10 (HDAC10) in B Cell Malignancies. Methods in molecular biology. 1436. 129–145. 6 indexed citations
4.
Lienlaf, Maritza, Patricio Perez-Villarroel, Tessa Knox, et al.. (2016). Essential role of HDAC6 in the regulation of PD‐L1 in melanoma. Molecular Oncology. 10(5). 735–750. 136 indexed citations
5.
Powers, John J., et al.. (2016). Modulation of T Cell Compartment in a Preclinical CLL Murine Model By a Selective PI3K Delta Inhibitor, TGR-1202. Blood. 128(22). 3236–3236. 4 indexed citations
6.
Powers, John J., Susan Deng, Steven N. Quayle, et al.. (2016). Combinatorial Effect of HDAC6i and Ibrutinib Therapy in CLL Murine Model. Blood. 128(22). 2035–2035.
7.
Knox, Tessa, Maritza Lienlaf, Patricio Pérez, et al.. (2016). Abstract 2331: HDAC6, new role as master regulator of PD-L1 and immune-related pathways. Cancer Research. 76(14_Supplement). 2331–2331. 1 indexed citations
8.
Sahakian, Eva, John J. Powers, Jie Chen, et al.. (2014). Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function. Molecular Immunology. 63(2). 579–585. 96 indexed citations
9.
Chen, Jie, Eva Sahakian, John J. Powers, et al.. (2014). Histone Deacetylase 11 (HDAC11) As a Novel Transcriptional Regulator of C/EBP-β, in Immature Myeloid Cell to Myeloid Derived Suppressor Cell Transition. Blood. 124(21). 225–225. 1 indexed citations
10.
Sahakian, Eva, Jason Brayer, John J. Powers, et al.. (2013). A Novel Role For Histone Deacetylase 11 (HDAC11) In Plasma Cell Differentation and Survival. Blood. 122(21). 1907–1907. 1 indexed citations
11.
Sahakian, Eva, John J. Powers, Jie Chen, et al.. (2013). A Novel Role For Histone Deacetylase 11 (HDAC11) As a Regulator Of Neutrophil Function and Differentiation In Normal and Malignant Hematopoesis. Blood. 122(21). 2267–2267. 1 indexed citations
12.
13.
Sahakian, Eva, John J. Powers, Jennifer Rock-Klotz, et al.. (2011). A Novel Role of Histone Deacetylase 11 (HDAC11) in Regulation of Myeloid-Derived Suppressor Cell (MDSC) Expansion. Blood. 118(21). 2439–2439. 1 indexed citations
14.
15.
Sahakian, Eva, Bijal Shah, John J. Powers, et al.. (2011). The Opposing Role of Histone Deacetylase 10 (HDAC10) and HDAC11 in Proliferation/Survival of Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL). Blood. 118(21). 1363–1363. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ben P. Martin Breakdown of academic impact, for papers by Kellie-Marie Banks Breakdown of academic impact, for papers by Laura Esteban-Burgos Breakdown of academic impact, for papers by Fanjun Cheng Breakdown of academic impact, for papers by Robert J. Van Gulick Breakdown of academic impact, for papers by Clemens Spinnler Breakdown of academic impact, for papers by Bonnie Huor Breakdown of academic impact, for papers by Caterina Mezzatesta Breakdown of academic impact, for papers by Hélène Ste-Croix Breakdown of academic impact, for papers by Lars A.T. Meijer
Rankless by CCL
2026